Richard Steinhart
Director of Finance/CFO at BIOXCEL THERAPEUTICS, INC.
Net worth: 12 487 $ as of 30/05/2024
Richard Steinhart active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director/Board Member | 07/11/2013 | - |
| Independent Dir/Board Member | 07/11/2013 | - | |
| ATOSSA THERAPEUTICS, INC. | Director/Board Member | 02/03/2014 | - |
| Independent Dir/Board Member | 28/02/2014 | - | |
| BIOXCEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30/09/2017 | - |
| Director of Finance/CFO | 30/09/2017 | - |
Career history of Richard Steinhart
Former positions of Richard Steinhart
| Companies | Position | Start | End |
|---|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Director of Finance/CFO | 13/10/2015 | 31/03/2017 |
| STRATA SKIN SCIENCES, INC. | Director of Finance/CFO | 23/04/2006 | 30/12/2013 |
| Corporate Secretary | 23/04/2006 | 30/12/2013 | |
| Treasurer | 23/04/2006 | 30/12/2013 | |
| TG THERAPEUTICS, INC. | Director/Board Member | 30/06/2004 | 31/12/2011 |
| Independent Dir/Board Member | 26/06/2011 | 31/12/2011 | |
| Forest Street Capital, LLC | Corporate Officer/Principal | 30/04/1992 | 23/04/2006 |
| EMISPHERE TECHNOLOGIES, INC. | Director of Finance/CFO | 30/04/1991 | 30/04/1992 |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Director of Finance/CFO | 31/12/1990 | 01/01/1992 |
| ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Training of Richard Steinhart
| Pace University | Masters Business Admin |
Statistics
International
| United States | 13 |
Operational
| Director of Finance/CFO | 6 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
Sectoral
| Health Technology | 8 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| STRATA SKIN SCIENCES, INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
CW Group, Inc.
CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
| Forest Street Capital, LLC | |
| SAE Ventures | |
| MELA Sciences Inc. |
- Stock Market
- Insiders
- Richard Steinhart
- Experience
